Company Filing History:
5 out of 23 
5 out of 8 
4 out of 7 
Years Active: 2018-2021
Title: Thierry Maugard: Innovator in Pharmaceutical Active Ingredients
Introduction:
Thierry Maugard, a distinguished inventor hailing from La Jarne, France, has made significant contributions to the field of pharmaceutical science. With a track record of five patents and a reputation for pioneering innovative solutions, Maugard has played a pivotal role in advancing the prevention and treatment of metabolic disorders in both humans and animals. Let's delve into his latest patents, noteworthy career highlights, and collaborations.
Latest Patents:
One of Maugard's recent patents is titled "Pharmaceutical Active Ingredient and Use Thereof, in Particular for the Prevention and Treatment of Metabolic Disorders in Humans and Animals." This invention centers around an active pharmaceutical ingredient comprising a unique combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(β-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate for pharmaceutical or veterinary use. This innovation holds immense promise in preventing and treating pathological disorders of carbohydrate and lipid metabolism.
Maugard's next patent, "Compositions and Methods for Controlling Carbohydrate and Fat Metabolism," focuses on a composition comprising extracts obtained from a mixture of at least two plants. This composition, particularly beneficial as a nutritional or health product, helps prevent and combat carbohydrate and fat metabolism disorders in humans and animals.
Career Highlights:
Thierry Maugard has had a successful career full of noteworthy achievements. He has worked with reputable institutions such as Universite Clermont Auvergne and Universite De La Rochelle, where he has made significant contributions to the field of pharmaceutical research. Through his innovative research and patent applications, Maugard has enhanced the understanding and treatment of metabolic disorders, leaving a lasting impact on the medical community.
Collaborations:
Maugard's commitment to innovation is further highlighted through his collaborations with esteemed colleagues. Two significant collaborations include his work with Sebastien Peltier and Pascal Sirvent. These fruitful partnerships have led to fruitful research and innovative solutions in the field of pharmaceutical science.
Conclusion:
Thierry Maugard's dedication and expertise have made him a prominent figure in the field of pharmaceutical active ingredients. With five patents to his name and a focus on the prevention and treatment of metabolic disorders, his contributions have opened new possibilities in human and animal healthcare. Collaborations with esteemed colleagues further strengthen his impact on the industry. Maugard's inventive spirit and commitment to improving lives serve as an inspiration to the scientific community, making him a true innovator in the field of pharmaceutical research.